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The malaria merozoite invades erythrocytes in the verte-
brate host. Iterative rounds of asexual intraerythrocytic
replication result in disease. Proteases play pivotal roles
in erythrocyte invasion, but little is understood about
their mode of action. The Plasmodium falciparummalaria
merozoite surface sheddase, PfSUB2, is one such poorly
characterized example. We have examined the molecu-
lar determinants that underlie the mechanisms by which
PfSUB2 is trafficked initially to invasion-associated apical
organelles (micronemes) and then across the surface of
the free merozoite. We show that authentic promoter
activity is important for correct localization of PfSUB2,
likely requiring canonical features within the intergenic
region 5′ of the pfsub2 locus.We further demonstrate that
trafficking of PfSUB2 beyond an early compartment in the
secretory pathway requires autocatalytic protease activ-
ity. Finally, we show that the PfSUB2 transmembrane
domain is required for microneme targeting, while the
cytoplasmic domain is essential for surface translocation
of the protease to the parasite posterior following dis-
charge from micronemes. The interplay of pre- and post-
translational regulatory elements that coordinate sub-
cellular trafficking of PfSUB2 provides the parasite with
exquisite control over enzyme–substrate interactions.
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Malaria is a debilitating disease that threatens at least 1
billion people, infects around 500million and is responsible
for approximately 1 million deaths each year (1). The
etiologic agent is the protozoan parasite Plasmodium spp,
which is transmitted through the bite of an infected female
Anopheline mosquito. Replication of the asexual blood-
stages of the parasite’s complex life cycle causes the
pathology of the disease. The asexual blood-stage life
cycle of the parasite divides into three distinct phases:
(i) invasion of the host erythrocyte by a merozoite; (ii)
growth and multiplication of the intracellular parasite
by schizogony to form new daughter merozoites; (iii)
merozoite release, through a process known as egress,
and subsequent reiteration of these events.
Erythrocyte invasion is driven by an actinomyosin motor
which, in association with other molecular partners, is
referred to as the glideosome (2–4). The merozoite
attaches to an erythrocyte, then as the motor drives
the parasite into the cell, components of the parasite
surface coat are shed through the action of at least
two serine proteases: a rhomboid called ROM4 (5)
and the merozoite surface sheddase, a member of the
subtilisin-like superfamily called PfSUB2 (6). Early electron
microscopic studies of erythrocyte invasion suggested
that the enzymes responsible for the proteolysis of surface
proteins localize to a region of close association between
the parasite and the host cell called the moving junction
(7), though a recent study has questioned this supposition
(8). The attachment of parasite proteins at the leading
edge of the junction is thought to drag the erythrocyte
membrane around the parasite, before being disengaged
at the parasite posterior pole by proteolysis (9). The
trafficking and compartmentalisation of substrates and
other components of this shedding machinery therefore
likely regulate invasion (10).
PfSUB2 is one of just three subtilisin-like proteases
encoded within the Plasmodium falciparum genome (11).
Like most subtilisins, PfSUB2 is expressed as a precursor
zymogen, which undergoes maturation from a 150 kDa
precursor (PfSUB2P), to a 75 kDa intermediate (PfSUB2I)
and then to the terminal 70 kDa mature form (PfSUB2T)
(12). For many subtilisins, maturation is a prerequisite
for progression through the secretory transport system
(13,14). On the basis of sensitivity to brefeldin A treatment,
the primary maturation step of PfSUB2 is thought to take
place in the endoplasmic reticulum (ER), with the second
occurring beyond this compartment (11).
PfSUB2 is targeted to two distinct subcellular locations in
the parasite. Initially PfSUB2 accumulates in a set of apical
secretory organelles called micronemes, which are known
to be the destination of other invasion factors (15,16).
Following merozoite egress, PfSUB2 is discharged from
these organelles and traffics across the surface of the
free merozoite in an actin-dependent fashion that can be
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disrupted by the actin destabilizing agent, latrunculin A (6).
At least one other microneme protein, apical membrane
antigen-1 (PfAMA1), is also discharged onto the surface
of the merozoite at egress. Interestingly, once released
the distribution of these two proteins, which were initially
in the same micronemal location becomes very different;
PfSUB2 caps as a tight focus at the posterior of the
parasite, whereas PfAMA1 distributes circumferentially
across the surface of the parasite via an apparently actin-
independent mechanism (17,18). These observations are
consistent with distinct mechanisms for the surface
trafficking of these two proteins.
PfAMA1, as well as two other surface proteins called
MSP1 and PTRAMP, are shed during invasion through the
action of PfSUB2 (6,19). Given the apparently essential
nature of this shedding (20–23), an understanding of the
trafficking of PfSUB2 to the micronemes and parasite
surface would enable dissection of the means by which
the parasite is able to package key invasion factors and the
protease responsible for their eventual release from the
parasite surface to the same subcellular compartment.
Knowledge of how PfSUB2 is brought into productive
contact with its substrates may offer new avenues for
the development of small molecules to interfere with this
process.
Here we have investigated the factors governing the
trafficking of PfSUB2.We provide evidence that trafficking
of PfSUB2 may be dependent upon canonical regulatory
features 5′ of the gene locus. An extended fragment of
the pfsub2 5′ intergenic region is required to reproduce
an authentic pattern of trafficking for an episomally
maintained transgene product. Trafficking of PfSUB2
was also found to be dependent upon autocatalytic
maturation, while an intact transmembrane domain and
the highly conserved juxtamembrane region are required
for correct microneme targeting. The cytoplasmic domain
(CD) was found to be required for actin-dependent surface
translocation of the protease. The results demonstrate
that the trafficking of PfSUB2 is governed by a range
of molecular determinants, requiring both pre- and post-
translational regulation.
Results
PfSUB2 expressed under the control of the pfama1
promoter is aberrantly trafficked
In previous work we epitope-tagged PfSUB2 in the para-
site by using single-crossover homologous recombination
to fuse a triple haemagglutinin tag (HA3) to the extreme
3′ end of the pfsub2 coding sequence (6). However,
repeated attempts to disrupt the pfsub2 gene or introduce
a GFP-tag proved unsuccessful. PfSUB2 is therefore likely
essential for the intracellular survival of the blood-stage
parasite. To study the factors involved in trafficking of
the protease we decided to establish a transgene expres-
sion system using epitope-tagged PfSUB2 (PfSUB2-HA)
transgenes carried on episomally maintained plasmids.
These constructs allow for the expression and study
of PfSUB2 mutants in the parasite on a background of
expression of the endogenous gene.
The transcriptional profile of pfsub2 closely matches
that of pfama1; transcription of both begins at around
43–45 h following erythrocyte invasion and peaks around
48 h post-infection (24,25). The pfama1 promoter is well
characterized and has been successfully used for the
transgenic expression of other late-stage P. falciparum
genes (23). We therefore initially attempted to express
PfSUB2-HA from an episomal transgene driven by the
pfama1 promoter. As can be seen from Figure 1A, the
transgene was successfully expressed and underwent
the expected maturation events involving conversion of
the precursor zymogen through an intermediate to the
terminal form. However, indirect immunofluorescence
assay (IFA) with HA-specific antibodies showed that
the transgene product only partially colocalized with the
endogenous microneme marker PfAMA1, with most of
the signal distributed between the parasite cytosol and
an undefined compartment between the nucleus and the
apically disposed micronemes (indicated by the white
arrowhead on the merged image for pfama1-sub2-HA in
Figure 1B). This could be due to retention of a proportion of
the transgene product in an early secretory compartment
such as the ER, or the Plasmodium equivalent of the
late endosome (LE) recently described for Toxoplasma
and thought to be a transitory organelle for microneme
proteins (26). This result suggested that although the
transcriptional profiles of pfama1 and pfsub2 are almost
superimposable, the corresponding promoters are not
functionally equivalent.
Canonical features 5 ′ of the pfsub2 locus may affect
gene expression and product localization
Correct trafficking of other Plasmodium gene products has
previously been shown to be dependent on the promoter
used to drive expression of the transgene (27–29).
We therefore investigated whether use of the native
pfsub2 promoter in our episomal system could correctly
reproduce the authentic pattern of PfSUB2 trafficking to
the micronemes.
The extreme AT bias of the Plasmodium genome, along
with a paucity of identifiable transcription factors has
made characterization of genomic regulatory elements
difficult (30). In spite of this, a consensus is beginning to
emerge; this is of a promoter structure similar to that of
the canonical eukaryotic type, with the standard features
of a major 5′ transcriptional start site, an enhancer region
and a transcription factor binding site. In light of this we
performed an in silico examination of the region 5′ of the
3D7 pfsub2 locus. The major 5′ transcription start site
has been previously mapped by us to position −1168bp
upstream of the start ATG (12). Further upstream of the
transcription start site there are multiple extended poly
A/T tracts, known to influence the position of transcription
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Figure 1: Mislocalization of PfSUB2 expressed from an episomally maintained transgene driven by the pfama1 promoter.
Synchronous late-stage schizonts were examined by western blot and indirect IFA. A) Schizont extracts were fractionated by SDS-PAGE,
transferred to nitrocellulose and probed with anti-HA mAb 3F10. Lanes (left to right): PfSUB2HA positive control; episomally expressed
HA3-tagged PfSUB2 transgene driven by the pfama1 promoter. The results show that the pfama1 promoter drives expression of an
episomally maintained pfsub2 transgene. Positions of the 150 kDa precursor (PfSUB2P), 75 kDa intermediate (PfSUB2I) and terminal
70 kDa form (PfSUB2T) are indicated. The filled star indicates a previously observed small HA-reactive product often present in the
PfSUB2HA parasite extracts (6). B) Fixed thin-blood films were probed with the anti-HAmAb (green) and an anti-PfAMA1 rabbit polyclonal
antibody (red). Parasite nuclei were counterstained with DAPI (blue). PfAMA1 localizes to micronemes at the apical end of the parasite.
Most of the signal intensity for the tagged endogenous gene product (PfSUB2HA) overlaps with that of PfAMA1 as previously observed
(6) (Pearson’s coefficient 0.927). In contrast, although a proportion of the episomally expressed PfSUB2 (pama1-sub2-HA) signal overlaps
with PfAMA1, a significant proportion localizes to an undefined cytosolic compartment (white arrowhead) (Pearson’s coefficient 0.628,
indicating the change in correlation of the signal intensities). Note that fluorescence intensities in IFA were not noticeably different
between the PfSUB2HA and pama1-sub2-HA lines, indicating similar transgene expression levels (data not shown). Scale bar, 8μm.
initiation (31). A recent study determined the recognition
sites for two members of the apicomplexan AP2 (ApiAP2)
family of transcription factors in P. falciparum (32). The
presence of these binding motifs in the region 5′ of a gene
was found to correlate with their expression profile during
the erythrocytic life cycle. However, the authors noted
that the transcription profiles of the AP2 transcription
factors do not necessarily match the transcription profiles
of target genes. Interestingly, the transcription profiles of
putative targets for the PF14_0633 ApiAP2 transcription
factor show a similar late-schizont expression profile to
that exhibited by pfsub2 (32). An examination of the
pfsub2 5′ flanking region identified a site that matched
the published consensus binding motif for PF14_0633
(GCATGC) (32), locating to position −1654bp (including
the six residues of the motif) upstream of the start ATG.
To investigate the relative contributions of each of these
features and any others that might have been overlooked,
a 2147-bp fragment (called Ff) of the pfsub2 5′ flanking
region was amplified from genomic parasite DNA and
cloned into the episomal PfSUB2-HA expression vector in
place of the pfama1 promoter. In addition three different
truncated forms of the same regionwere similarly inserted
into the vector. The resulting four constructs were then
transfected separately into the parasite and assessed in
parallel for their capacity to drive expression and correct
trafficking of the PfSUB2-HA transgene product. Figure 2
shows a schematic representation of this strategy, and
highlights the features identified from the in silico
examination detailed above. As shown in Figure 3A, all
four putative promoter sequences (F3, F2, F1 and Ff)
successfully drove expression of the pfsub2 transgene, as
well as the correct pattern of post-translational maturation
of the transgene product. However, IFA with the anti-HA
antibody showed that in 3 of 4 cases the subcellular
localization differed significantly from the PfSUB2-HA
control line in which the endogenous gene has been
HA-tagged (Figure 3B). Expression from the F3 and F2
promoter fragments resulted in the majority of the IFA
signal being diffusely distributed throughout the schizont
(Figure 3B). This suggested that the inclusion in the
promoter of the previously mapped major 5′ transcription
start site was not sufficient to correctly target the
expressed product to the micronemes. The IFA signal
resulting from expression from the F1 fragment was
more punctate (Figure 3B), with the majority of the
signal correctly colocalizing with the microneme marker
PfAMA1. However, it was not as tightly restricted to
this apical compartment as observed for the endogenous
gene product, and indeed was similar to the localization
pattern observed for transgene expression driven by the
pfama1 promoter (Figure 1B). In contrast, expression
of the PfSUB2-HA transgene under control of the Ff
fragment matched the localization pattern seen for the
tagged endogenous gene product (Figure 3B); expression
was tightly restricted to the apical end of the developing
intracellular merozoites, with the product predominantly
colocalizing with PfAMA1.
From these data, we conclude that correct subcellular
localization of an episomally maintained pfsub2 transgene
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Figure 2: Examination of the pfsub2 5′ flanking region. Schematic representation (not to scale) of the intergenic sequence lying 5′
to the pfsub2 locus, and the four different regions examined for promoter activity (Ff, F1, F2 and F3). The position of the previously
mapped major 5′ transcriptional start site at −1168 bp and the putative ApiAP2 transcription factor binding site at −1654 bp are indicated
in relation to the different promoter fragments and their distance from the ATG start codon of the pfsub2 coding sequence (position 0).
product is strictly dependent upon the promoter used
to drive its expression. The observation that the Ff
promoter but not the truncated fragments enables correct
targeting of an ectopically expressed protease suggests
that critical regulatory elements for appropriate expression
lie between−1463 and−1654bp upstream of the PfSUB2
start codon. However, further mutagenesis studies will
be required to confirm and precisely define the nature
of those elements. The Ff-containing episomal construct
was therefore used for all subsequent trafficking studies
described unless otherwise stated.
Primary proteolytic maturation of PfSUB2 is
autocatalytic and is required for trafficking beyond an
early secretory compartment
In common with the majority of subtilisin-like proteases,
PfSUB2 undergoes proteolytic maturation (12). By analogy
with other subtilisins, it is likely that the primary
step of this maturation is autocatalytic, but this has
yet to be confirmed. The autocatalytic maturation of
several secreted eukaryotic subtilisins is associated with
progression through the secretory transport system
(14,33). However, the relationship between proteolytic
maturation of PfSUB2 and its trafficking is unknown.
To address both of these points, we exploited the PfSUB2-
HA episomal expression system described above to
examine the consequences of substitution of the putative
catalytic Ser residue, S960, with an Ala residue (S960A).
This mutation has been shown to render subtilisin-
like proteases catalytically inactive, but to have little
effect upon the 3-dimensional architecture of the active
site cleft (34). As shown in Figure 4A, the transgenic
PfSUB2-HA S960A mutant but did not undergo detectable
maturation beyond the 150 kDa zymogen precursor,
strongly suggesting that the primary maturation step is
autocatalytic. Since expression of this mutant was on
the background of normal expression of endogenous
PfSUB2, this observation additionally suggests that the
primary autocatalytic maturation step is an intramolecular
event that cannot efficiently occur in trans. Examination
of the PfSUB2-HA S960A-expressing line confirmed
that the mutant transgene product did not localize to
the micronemes, instead appearing to be restricted
to a perinuclear location likely corresponding to an
early secretory compartment (indicated by the white
arrowheads in Figure 4B). We have previously shown
that brefeldin A, a fungal metabolite that interferes with
anterograde protein transport from the ER to the Golgi,
induces accumulation of the 75 kDa PfSUB2I intermediate,
indicating that primary processing of PfSUB2 occurs in the
ER. These new data are consistent with that, although
efforts to colocalize the aberrantly trafficked PfSUB2-
S960A with antibodies to the ER marker PfBip were
unsuccessful (data not shown). Collectively, these data
suggest that firstly, primary maturation of PfSUB2 is
autocatalytic and occurs in a non-micronemal secretory
compartment (that is likely the ER), and secondly that
proteolytic maturation of the protease is required for
trafficking beyond this compartment to the micronemes.
Autocatalytic processing of PfSUB2may serve as a quality
control checkpoint for transit of the protease beyond
the ER.
The transmembrane and CDs of PfSUB2 are not
required for enzyme activity
The PfSUB2 primary translation product comprises a
secretory signal, an extended N-terminal prodomain,
a putative catalytic domain and a highly conserved
juxtamembrane structure. This is followed by a putative
membrane-spanning sequence typical of type I integral
membrane proteins, and finally a C-terminal CD which
varies somewhat in length between different SUB2
orthologues (Figure S1). Having established that catalytic
activity of the protease is important for trafficking, we
investigated the role of the different putative domains
for activity and trafficking of the protease. Since the
prodomain of many subtilisins is required for folding
(14), we decided to evaluate a series of episomal
PfSUB2-HA expression constructs in which the gene
had been progressively truncated from the C-terminus.
These deletion mutants were expressed episomally in the
parasite under the control of the Ff promoter sequence.
As shown in Figure 5A, the constructs tested consisted
of deletions of the cytoplasmic domain (CD), both the
cytoplasmic and transmembrane domains (Tm+CD),
or the entire conserved juxtamembrane, transmembrane
and cytoplasmic domains (Jx+Tm+CD). Since we had
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Figure 3: Episomal expression of PfSUB2 driven by pfsub2 5′ flanking sequences. western blot and IFA analysis of PfSUB2
expressed under the control of different promoter lengths. A) Extracts of segmented schizonts were fractionated by SDS-PAGE,
transferred to nitrocellulose and probed with anti-HA mAb 3F10. Lanes (from left to right): parental wild-type 3D7 (negative control);
PfSUB2HA positive control; episomal HA3-tagged PfSUB2 transgene driven by the F3 promoter; episomal HA3-tagged PfSUB2 transgene
driven by the F2 promoter; episomal HA3-tagged PfSUB2 transgene driven by the F1 promoter; episomal HA3-tagged PfSUB2 transgene
driven by the Ff promoter. The filled star highlights the previously observed small anti-HA-reactive product in extracts of the control
PfSUB2HA clone, and the open star highlights an additional anti-HA reactive species in the F3 transgenic line. B) Formaldehyde-fixed,
thin-blood films of segmented schizonts were probed with the anti-HA mAb (green) or an anti-PfAMA1 rabbit polyclonal antibody (red).
Nuclei were counterstained with DAPI (blue). PfAMA1 localizes to the micronemes at the apical end of the parasite. The majority of
the PfSUB2 signal when expressed under the control of the F3 and F2 promoter fragments does not overlap with the PfAMA1 signal
(Pearson’s coefficient 0.183 and 0.518, respectively). While a significant proportion of the product expressed under the control of the
F1 promoter correctly localizes to the micronemes (Pearson’s coefficient 0.637), the Ff promoter results in greater overlap between the
PfSUB2 and PfAMA1 signals, and is the only one that produces an authentic micronemal pattern of localization (Pearson’s coefficient
0.682). Note that fluorescence intensities in IFA were not noticeably different between the various parasite lines, indicating similar
transgene expression levels (data not shown). Scale bar, 8μm.
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Figure 4: Proteolytic maturation of PfSUB2 is autocatalytic and required for trafficking to micronemes. Western blot and IFA
analyses of wild-type and catalytically inactive PfSUB2. A) Extracts of segmented schizonts were fractionated by SDS-PAGE, transferred
to nitrocellulose and probed with anti-HA mAb 3F10. Lanes (from left to right): parental wild-type 3D7 (negative control); Ff-sub2,
episomal HA3-tagged PfSUB2 transgene driven by the Ff promoter (positive control); Ff-sub2-S960A, PfSUB2 S960A catalytic mutant
driven by the Ff promoter. The PfSUB2-S960A mutant is expressed, but does not undergo post-translational proteolytic maturation.
B) IFA examination of the subcellular localization of the PfSUB2-S960A mutant. Correct microneme targeting was assessed as before
through colocalization with the microneme marker protein PfAMA1, and generation of Pearson’s coefficients to indicate correlation of
signal intensities. Formaldehyde-fixed parasites were probed with the anti-HA mAb 3F10 (green) and anti-PfAMA1 rabbit polyclonal
antibody (red), with the nuclei counterstained with DAPI (blue). Controls: PfSUB2HA, Ff-sub2 (wild-type episome) (Pearson’s coefficient
0.723). The unprocessed PfSUB2-S960A mutant remains restricted to a perinuclear location between the nucleus and the apical end of
the parasite (indicated by white arrowheads), with greatly reduced overlap between the signals (Pearson’s coefficient 0.141). Scale bar,
8μm.
already demonstrated that catalytically inactive protease
could not progress beyond the zymogen precursor, we
initially assessed the different regions for their contribution
to protease activity. Parasites harbouring each transgene
expression construct were established by transfection and
drug selection, and then mature schizont stage parasites
isolated and examined bywestern blot. As shown in Figure
5B, all the deletion mutants were successfully expressed
in the parasite, and all underwent maturation beyond the
zymogen precursor to a smaller truncated mature form.
Interestingly, the CD zymogen precursor could not be
visualised perhaps indicating that autocatalytic maturation
is more efficient in the absence of the CD. Although it
remains a formal possibility that other proteases within
the secretory transport system could be responsible
for the proteolytic cleavage of the truncated products,
these data strongly suggest that neither the cytoplasmic,
transmembrane nor juxtamembrane domains of PfSUB2
are required for autocatalytic activity.
PfSUB2 catalytic activity is not sufficient for
trafficking beyond an early secretory compartment
Following the observation that none of the above
truncations affected the catalytic activity of PfSUB2, we
next investigated the effects of the truncations upon
trafficking. Wild-type PfSUB2 is stored in micronemes
in mature schizonts, and is then discharged to translocate
across the surface of free merozoites following egress
and around the time of reinvasion (6). In the first
instance we therefore investigated whether the truncated
proteins were correctly targeted tomicronemes. TheCD
mutant was correctly targeted to micronemes (Figure 6),
indicating that the CD of the protease is not required for
sorting and trafficking beyond the ER. In contrast, IFA
analysis of parasites expressing the Tm+CD mutant
revealed that, similar to the S960A mutant, trafficking
was aberrant with the transgene product localizing to a
site between the nuclear body and the apical end of
the parasite (Figure 6). This finding demonstrates that
catalytic activity alone (as determined by a capacity to
undergo the primary step of maturation) is not sufficient to
promote progression of theTm+CDmutant through the
secretory pathway. The mutant Jx+Tm+CD protein
lacking the conserved juxtamembrane region similarly
did not progress beyond the putative early secretory
compartment (Figure 6). Given the inability of the
Tm+CD mutant to progress beyond a compartment
that was similar in appearance, the precise role of the
juxtamembrane region in PfSUB2 trafficking could not be
further assessed.
The CD of PfSUB2 is required for correct surface
trafficking
Upon merozoite egress, PfSUB2 is discharged from
micronemes to traffic across the free merozoite surface
and cap as an intense focus at the posterior pole of the
parasite. Previous studies have shown that this surface
translocation can be inhibited by the actin-destabilising
agent latrunculin A (6). The only truncation mutant that
correctly localized to micronemes was the CD mutant
in which the CD had been removed. Therefore, we next
examined the trafficking of the CD protease across the
surface of merozoites following egress.
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Figure 5: The cytoplasmic, transmembrane and juxtamembrane domains of PfSUB2 are not required for autocatalytic
maturation. Schematic of progressive C-terminal gene truncation strategy and western blot of expressed truncated products. A)
Schematic representation of truncated episomal expression constructs made through progressive C-terminal deletions of the pfsub2
gene (not to scale). B) Extracts of segmented schizonts were fractionated by SDS-PAGE, transferred to nitrocellulose and probed with
anti-HA mAb 3F10. Lanes (from left to right): parental wild-type 3D7 negative control; HA3-tagged full-length PfSUB2 episomal transgene
(WT); Ff-sub2-S960A, PfSUB2 catalytic mutant (S960A); HA3-tagged PfSUB2 transgene lacking the cytoplasmic domain (CD); HA3-
tagged PfSUB2 transgene lacking the transmembrane and cytoplasmic domains (Tm+CD); HA3-tagged PfSUB2 transgene lacking the
juxtamembrane, cytoplasmic and transmembrane domains (Jx+ Tm+CD). Truncated gene products are expressed as appropriately
truncated precursors (asterisked) that undergo autocatalytic maturation to smaller mature protease species (arrowed).
As shown in Figure 7, the IFA signal for the CD mutant
presented a strong reaction with the periphery of the
parasite, with the signal apparently uniformly distributed
across the surface of merozoites. It completely colocalized
with the PfAMA1 signal. The pattern clearly differed from
that observed for the wild-type protease (Figure 7), and
was reminiscent of the pattern of PfSUB2 distribution
in parasites treated with latrunculin A (6). The aberrant
localization of the CD mutant protease suggests that
although the CD is not required for targeting of PfSUB2
to the micronemes, it is necessary for the subsequent
actin-dependent surface translocation of the protease
across the merozoite surface, likely essential for efficient
cleavage of its membrane-bound substrates.
Discussion
Following egress, many components of the merozoite
surface coat are shed into the extracellular milieu. Some
of these proteins, such as MSP1 and PfAMA1 are
essential for viability of the parasite. PfSUB2 is regarded
as the principal merozoite surface sheddase (6). The
trafficking and compartmentalisation of substrates and
other components of the sheddingmachinerymay provide
spatial and temporal control of PfSUB2 functions, so an
understanding of how PfSUB2 is trafficked is necessary
for understanding the regulation of its interaction with
substrates. PfSUB2 is trafficked initially to micronemes,
and then across the surface of the parasite in an actin-
dependent manner, but the mechanisms employed for
this targeting are unknown (6). The data presented here
have demonstrated that this trafficking is dependent upon
a variety of pre- and post-translational regulatory elements,
and have begun to elucidate some of the molecular
features involved.
The pfsub2 promoter affects trafficking of the gene
product
Combining an in silico examination of the PfSUB2 5′ UTR
with a series of promoter constructs we determined that
the pfsub2 promoter plays a key role in correct trafficking
of the protein to micronemes. In general, eukaryotic
promoters comprise the following canonical features:
a major 5′ transcription start site, enhancer/repressor
regions and putative transcription factor binding sites.
Many of these features appear to be conserved in
Plasmodium promoters (35,36). The exact nature of the
elements present in the region 5′ of the pfsub2 locus
required for trafficking remains undetermined. Although
the 5′ major transcription start site was absent from the
F3 construct, there are typically multiple sites within the 5′
region of Plasmodium genes that can be used for initiation
of transcription (31,37). Therefore, any role played by
the inclusion of this mapped site within the promoter
is likely minor. As for other Plasmodium genes, it is
possible that the inclusion of an enhancer or repressor
region may also be important (38). However, given the
difficulty of characterizing these elements and the highly
repetitive nature of the 5′ intergenic regions, definitive
confirmation of this would require considerable further
work. A putative ApiAP2 transcription factor binding site
was identified 1654 bp upstream of the start methionine.
This was particularly intriguing as the transcription profiles
of putative target genes for this transcription factor match
that of pfsub2 (32), and so this site was included in
the longest promoter fragment examined. The ApiAP2
family of transcription factors has received considerable
attention (30,39), since the stage-specific transcription
profile of this family of transcription factors mirrors the
general pattern of transcription initiated upon invasion of
the host erythrocyte (24,40). Mislocalization of PfSUB2
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Figure 6: The PfSUB2 transmembrane domain is required for correct trafficking to micronemes. IFA analysis of schizonts
expressing truncated episomal PfSUB2 constructs. Fixed thin-blood films were probed with the anti-HA mAb 3F10 (green), and
anti-PfAMA1 rabbit polyclonal antibody (red). Nuclei were counterstained with DAPI (blue). PfSUB2 lacking the cytoplasmic domain
(CD) correctly localizes to micronemes, with a high degree of correlation of the signal intensities (Pearson’s coefficient 0.734). PfSUB2
mutants further truncated of the transmembrane or juxtamembrane domains (Tm+CD and Jx+ Tm+CD) do not localize to the
micronemes but are restricted to a compartment similar to the inactive gene product, with greatly reduced overlap between the signal
intensities (Pearson’s coefficient 0.254 and 0.177, respectively). Scale bar, 8μm.
when expressed under the wrong promoter element(s) is
likely due to incorrect timing and/or levels of expression.
Our data add to a growing body of work examining
the promoters of other Plasmodium genes such as
pfresa, pfama1, pfmsp2 and pfeba175 (28,41–43), and
support the conclusion that in order to recapitulate correct
trafficking of a transgene product, the complete native
promoter for the gene should be used.
Proteolytic maturation of PfSUB2 is required for
trafficking
Our results show that autocatalytic processing of PfSUB2
is linked to its progression through the secretory path-
way (13). Earlier work demonstrated that treatment of
the parasites with brefeldin A, which interferes with
anterograde protein transport from the ER to the Golgi,
did not block the primary processing of PfSUB2 (11).
This suggested that primary processing occurs in the
ER. Our observation here that the catalytically dead
PfSUB2 mutant, PfSUB2-S960A, did not progress beyond
an ER-like compartment suggests that processing may
serve as a quality control for progression through the
secretory pathway. Retention of PfSUB2-S960A in the
ER was not conclusively demonstrated, but the weight of
evidence would suggest that the unprocessed protease
is retained within this compartment. Alternatively, it
is possible that the retained PfSUB2 is located within
the Plasmodium equivalent of the recently described
Toxoplasma gondii LE, thought to be an intermediate
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Figure 7: The cytoplasmic domain of PfSUB2 is required for correct surface translocation and posterior capping. IFA analysis of
free merozoites expressing WT PfSUB2HA or the CD mutant. Formaldehyde-fixed parasites were probed with the anti-HA mAb 3F10
(green) and anti-PfAMA1 rabbit polyclonal antibody (red). Nuclei were counterstained with DAPI (blue). Wild-type PfSUB2 is secreted
from the micronemes and trafficked across the surface of free merozoites in an actin-dependent fashion before capping as a posterior
focus (white arrowheads) PfAMA1 is secreted from the micronemes and distributes to a uniform circumferential pattern. There is almost
no overlap of the WT PfSUB2 and PfAMA1 signals (Pearson’s coefficient 0.008). In contrast, the surface distribution of CD PfSUB2
matches that of PfAMA1, with a high degree of correlation between the signals (Pearson’s coefficient 0.74). Scale bar, 8μm (upper 2
rows of images). The lower set of eight panels have been enlarged to better illustrate the differences in distribution of the markers used
(Pearson’s coefficients −0.048 for WT PfSUB2 and 0.824 for CD PfSUB2).
compartment situated between the ER/Golgi and the
apical organelles in the secretory transport system of this
related apicomplexan (26).
Truncation of PfSUB2 affects its localization
Similar to previous data from studies of PfAMA1,
PfEBA175, PfEBA181 and PfEBA140 (41), we found
that PfSUB2 lacking its CD was correctly trafficked to
micronemes. Surprisingly, despite multiple attempts, the
PfSUB2 CD precursor was never detectable by western
blot in schizont extracts. One possible interpretation of
this finding is that removal of the CD increases the rate
of autocatalytic maturation of the zymogen precursor. The
CD could play a regulatory role in this event, ensuring
that activation and further trafficking only occur following
further translocation through the ER.
The CD mutant was correctly trafficked to micronemes,
and it is intriguing to consider how this would occur. It is
possible that PfSUB2 could interact with a chaperone-
type protein in the ER that would regulate further
downstream trafficking. This would be analogous to
the situation seen in T. gondii for MIC2 and M2AP,
where membrane-bound MIC2 interacts and cotraffics
with the soluble M2AP (44,45). Upon merozoite egress,
the CD protein was discharged from micronemes,
showing that release of PfSUB2 from the micronemes
is not dependent upon the CD. However, its subsequent
distribution on the merozoite surface was atypical,
matching that of PfAMA1, translocation of which is
not actin-dependent (46). The PfSUB2 CD may be
responsible for mediating interactionswith components of
the actinomyosin motor. To further explore this possibility,
we made a more detailed examination of the CDs
of all the Plasmodium SUB2 orthologues (Figure S1).
Alignments of the CDs highlight the lack of conservation.
A recent study implicated phosphorylation of the CD of
another microneme protein, PfAMA1, as playing a key
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role in the function of the molecule (42). Examination
of a recently published P. falciparum phosphoproteome
identified a phosphorylation site within the cytoplasmic tail
of PfSUB2 (47). Further studies are underway to determine
whether phosphorylation of the PfSUB2 cytoplasmic tail
represents a post-translational modification required for
PfSUB2 trafficking and activity.
PfSUB2 catalytic activity was shown to be indepen-
dent of its membrane-associated conformation, since the
Tm+CD truncation did not apparently affect autocat-
alytic maturation. The fact that the Tm+CD mutant
was active in a fully soluble form makes it ideally suit-
able for renewed attempts at recombinant expression of
active enzyme, which has not yet been achieved. Although
the Tm+CD mutant was active, it was retained in an
ER-like compartment. Coupled with the data from the
PfSUB2-S960A mutant, this shows that catalytic activ-
ity and autocatalytical processing are not sufficient for
trafficking beyond this compartment.
The juxtamembrane region of PfSUB2 is the most highly
conserved portion of the molecule. The Jx+Tm+CD
mutant exhibited autocatalytic processing but was
retained in the ER-like compartment, in accord with our
previous observation that the transmembrane domain
of the protease is required for its progression through
the secretory pathway. It is difficult to draw any further
conclusions as to the functions of the juxtamembrane
region of PfSUB2, and in future experiments it may be
necessary to selectively delete it in order to fully examine
the role that it plays in trafficking of the molecule. From
the results of theCD truncation, it would appear that the
cytoplasmic tail is necessary only for the surface trafficking
of the protease, and therefore the juxtamembrane region
may have a role in microneme trafficking, similar to the
cysteine-rich region VI of the EBA family (41,48).
In conclusion, we have demonstrated that a variety of
pre- and post-translational regulatory features govern the
trafficking of PfSUB2. Future work will focus upon the
role of the highly conserved juxtamembrane region and
the CD, whichmay provide evidence of trafficking partners
and potential roles in signalling.
Materials and Methods
Parasite maintenance, synchronization and
transfection
Asexual blood-stages of P. falciparum clone 3D7 were maintained in RPMI-
1640 Albumaxmedium (GIBCO™), with the addition of 2mML-glutamine, at
2-4% haematocrit (49). Mature schizont stage parasites were isolated on a
70% (v/v) Percoll (GEHealthcare) density gradient as described (50). Further
synchronization using 5%D-sorbitol was performed as previously described
(51). For transfections, ring stage parasites at 5–10% parasitaemia were
electroporated as previously described (52).
Transfection constructs
Parasite vectors were all based on the pHH1 transfection plasmid (53). This
vector contains the P. berghei dihydrofolate reductase 3′ UTR (54), and the
human dihydrofolate reductase (hdhfr) selection cassette, which confers
resistance to the antifolate drug WR99210 (Jacobus Pharmaceuticals).
pfsub2 promoter constructs for episomal expression
Promoter fragments were amplified directly from 3D7 genomic DNA with
primers designed to incorporate 5′ Hpa I and 3′ Spe I restriction enzyme
sites. The PCR products were digested with Hpa I, Spe I and cloned
into identical sites in the pHH1 vector containing the Pfama1 promoter
(54) and the sub2 synthetic gene (pfsub2synth) (6), to create constructs
psub2-sub2wHA3-PEX, psub2-sub2wHA3-F1, psub2-sub2wHA3-F2 and
psub2-sub2wHA3-F3.
pfsub2 catalytic mutant
The codon in pfsub2synth encoding putative catalytic nucleophile Ser960
was mutated to an Ala codon (S960A) by site-directed mutagenesis (SDM)
using the QuikChange® Site-Directed Mutagenesis Kit (Stratagene), and
verified by nucleotide sequencing.
pfsub2 truncation constructs
The Xho I/Not I restriction enzyme fragment of pfsub2synth was excised
from psub2x-sub2wHA3-PEX and subcloned into identical sites in pGEX-
6P-1-HA3 to create pGEX-sub2HA3-Xho I/Not I. SDMwas used to introduce
an additional Cla I restriction enzyme site at the 5′ limit of the fragment that
was to be truncated, such that the region to be truncated would be flanked
by Cla I sites. Subsequent digestion with Cla I and religation generated the
different truncation fragments. The Xho I/Not I fragment was then excised
from this vector and subcloned back into psub2x-sub2wHA3-PEX to create
all the truncation constructs described.
Western blots
Western blots were performed as previously described (20). Briefly,
40mL cultures of Percoll-enriched schizonts were centrifuged and pelleted
parasites treated with 0.15% (w/v) saponin for 3min at 4◦C. The released
parasites were pelleted by centrifugation, washed and resuspended in
100μL 2× sodium dodecyl sulphate (SDS) sample buffer. Protein samples
were electrophoresed on 7.5–12.5% SDS polyacrylamide gels (SDS-
PAGE) and transferred to Hybond-C extra nitrocellulose membrane (GE
Healthcare). Membranes were blocked and probed with the antibody
described.
Immunofluorescence assay
IFA was performed as described (20). Briefly, thin films of P. falciparum
schizonts or naturally egressed merozoites were air-dried and fixed in 4%
paraformaldehyde for 30min, then permeabilized using 0.1% (v/v) Triton-X
100 (Sigma Pharmaceuticals) for 10min, washed twice with PBS for 5min
and then blocked overnight at 4◦C in 3% (w/v) bovine serum albumin
(BSA) in PBS. Samples were then probed with the antibodies specified.
Fluorescence images were acquired using a Zeiss Axioplan 2 Imaging
system (Carl Zeiss) and AXIOVISION 3.1 software.
Image analysis for colocalization
Images were processed for the degree of colocalization of signals obtained
with different antibody probes using IMAGEJ and the JACOP plugin as
described by Bolte and Cordelieres (55). Costes’ automatic threshold
function within the plugin was used to generate the Pearson’s correlation
coefficient values for the degree of colocalization. Briefly, this outputs a
numerical figure between−1 and 1, with 1 representing perfect correlation,
−1 being negative correlation (mutual exclusion), and 0 being no correlation
of signal intensities.
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Supporting Information
Additional Supporting Information may be found in the online version of
this article:
Figure S1: Alignment of Plasmodium spp. SUB2 orthologues showing
a heat map of amino-acid conservation (associated with Figure 5).
The comparison was performed using the PRALINE alignment software
(http://www.ibi.vu.nl/programs/pralinewww/). falciparum, P. falciparum
clone 3D7; vivax, P. vivax Salvador I isolate; knowlesi, P. knowlesi H
strain; yoelii, P. yoelii yoelii; berghei, P. berghei ANKA; P. cynomolgi.
Features of note, including the highly conserved juxtamembrane region
and the relatively poorly conserved cytoplasmic domain, are annotated
below the alignment.
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